BioCorRx Inc.
BICX
$0.41
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10,389.47% | 3,478.49% | 755.46% | 166.09% | -91.46% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10,389.47% | 3,478.49% | 755.46% | 166.09% | -91.46% |
| Cost of Revenue | 1,182.35% | 2,324.32% | -100.00% | -100.00% | -95.29% |
| Gross Profit | 12,823.33% | 4,853.78% | 1,620.33% | 491.06% | -88.74% |
| SG&A Expenses | 5.03% | 18.09% | 40.46% | 32.49% | 25.65% |
| Depreciation & Amortization | 32.93% | 578.36% | 334.70% | 91.04% | 23.51% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.72% | 31.43% | 31.01% | 39.39% | 33.98% |
| Operating Income | 5.68% | -12.48% | -24.58% | -37.61% | -36.97% |
| Income Before Tax | 32.68% | 13.90% | -15.37% | -20.74% | -38.24% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 32.68% | 13.90% | -15.37% | -20.74% | -38.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -35.19% | -2,150.80% | 1,178.42% | 3,302.94% | 2,844.44% |
| Net Income | 32.63% | -5.04% | -10.21% | -17.94% | -35.55% |
| EBIT | 5.68% | -12.48% | -24.58% | -37.61% | -36.97% |
| EBITDA | 8.60% | -9.32% | -22.56% | -37.21% | -37.06% |
| EPS Basic | 57.82% | 37.25% | 26.36% | 11.12% | -9.86% |
| Normalized Basic EPS | 57.45% | 32.77% | 33.52% | 16.34% | -7.63% |
| EPS Diluted | 57.82% | 37.25% | 26.36% | 11.31% | -9.62% |
| Normalized Diluted EPS | 57.45% | 32.77% | 33.52% | 16.34% | -7.63% |
| Average Basic Shares Outstanding | 75.67% | 66.86% | 57.53% | 40.13% | 25.40% |
| Average Diluted Shares Outstanding | 75.67% | 66.86% | 57.53% | 40.13% | 25.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |